Orion Oyj Top Insiders
ORINFDelisted Stock | USD 38.38 0.00 0.00% |
Orion Oyj employs about 3.5 K people. The company is managed by 9 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 388.89 employees per reported executive. Examination of Orion Oyj's management performance can provide insight into the company performance.
Timo Lappalainen Chairman President CEO, Chairman of the Executive Management Board |
Liisa Hurme President Senior Vice President Specialty Products and Fermion; Member of the Executive Management Board |
Orion |
Orion Oyj Management Team Effectiveness
The company has return on total asset (ROA) of 0.2077 % which means that it generated a profit of $0.2077 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4065 %, meaning that it generated $0.4065 on every $100 dollars invested by stockholders. Orion Oyj's management efficiency ratios could be used to measure how well Orion Oyj manages its routine affairs as well as how well it operates its assets and liabilities.Orion Oyj Workforce Comparison
Orion Oyj is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is now estimated at about 264,469. Orion Oyj claims roughly 3,500 in number of employees contributing just under 2% to equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.26 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33. Orion Oyj Notable Stakeholders
An Orion Oyj stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Orion Oyj often face trade-offs trying to please all of them. Orion Oyj's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Orion Oyj's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Timo Lappalainen | President CEO, Chairman of the Executive Management Board | Profile | |
Liisa Hurme | Senior Vice President Specialty Products and Fermion; Member of the Executive Management Board | Profile | |
Terhi Ormio | VP Communications | Profile | |
MBA M | Sr Board | Profile | |
Juhani Kankaanpaa | Sr Board | Profile | |
Olli LlM | Gen Functions | Profile | |
Tuukka MSc | Investor Officer | Profile | |
Pr MD | Sr Board | Profile | |
MSc MSc | Sr Board | Profile |
About Orion Oyj Management Performance
The success or failure of an entity such as Orion Oyj often depends on how effective the management is. Orion Oyj management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Orion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Orion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients in Finland, Scandinavia, other European countries, North America, and internationally. Orion Oyj has partnership with Propeller Health to connect the Easyhaler line of inhalers for asthma and COPD to Propellers digital medicine platform and a research collaboration and license agreement with Alligator Bioscience AB to discover and develop new bispecific antibody cancer therapeutics. Orion Corp is traded on OTC Exchange in the United States.
Orion Oyj Workforce Analysis
Traditionally, organizations such as Orion Oyj use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Orion Oyj within its industry.Orion Oyj Manpower Efficiency
Return on Orion Oyj Manpower
Revenue Per Employee | 297.4K | |
Revenue Per Executive | 115.7M | |
Net Income Per Employee | 55.4K | |
Net Income Per Executive | 21.5M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Orion Pink Sheet
If you are still planning to invest in Orion Oyj check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orion Oyj's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |